AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS. Mediterr J Hematol Infect Dis 2014, 6 (1), e2014047. https://doi.org/10.4084/mjhid.2014.047.